Obesity in Adults: A 2022 Adapted Clinical Practice Guideline for Ireland.
Clinical practice guideline
Ireland
Obesity
Journal
Obesity facts
ISSN: 1662-4033
Titre abrégé: Obes Facts
Pays: Switzerland
ID NLM: 101469429
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
07
2022
accepted:
06
09
2022
pubmed:
25
10
2022
medline:
29
11
2022
entrez:
24
10
2022
Statut:
ppublish
Résumé
This Clinical Practice Guideline (CPG) for the management of obesity in adults in Ireland, adapted from the Canadian CPG, defines obesity as a complex chronic disease characterised by excess or dysfunctional adiposity that impairs health. The guideline reflects substantial advances in the understanding of the determinants, pathophysiology, assessment, and treatment of obesity. It shifts the focus of obesity management toward improving patient-centred health outcomes, functional outcomes, and social and economic participation, rather than weight loss alone. It gives recommendations for care that are underpinned by evidence-based principles of chronic disease management; validate patients' lived experiences; move beyond simplistic approaches of "eat less, move more" and address the root drivers of obesity. People living with obesity face substantial bias and stigma, which contribute to increased morbidity and mortality independent of body weight. Education is needed for all healthcare professionals in Ireland to address the gap in skills, increase knowledge of evidence-based practice, and eliminate bias and stigma in healthcare settings. We call for people living with obesity in Ireland to have access to evidence-informed care, including medical, medical nutrition therapy, physical activity and physical rehabilitation interventions, psychological interventions, pharmacotherapy, and bariatric surgery. This can be best achieved by resourcing and fully implementing the Model of Care for the Management of Adult Overweight and Obesity. To address health inequalities, we also call for the inclusion of obesity in the Structured Chronic Disease Management Programme and for pharmacotherapy reimbursement, to ensure equal access to treatment based on health-need rather than ability to pay.
Sections du résumé
BACKGROUND
This Clinical Practice Guideline (CPG) for the management of obesity in adults in Ireland, adapted from the Canadian CPG, defines obesity as a complex chronic disease characterised by excess or dysfunctional adiposity that impairs health. The guideline reflects substantial advances in the understanding of the determinants, pathophysiology, assessment, and treatment of obesity.
SUMMARY
It shifts the focus of obesity management toward improving patient-centred health outcomes, functional outcomes, and social and economic participation, rather than weight loss alone. It gives recommendations for care that are underpinned by evidence-based principles of chronic disease management; validate patients' lived experiences; move beyond simplistic approaches of "eat less, move more" and address the root drivers of obesity.
KEY MESSAGES
People living with obesity face substantial bias and stigma, which contribute to increased morbidity and mortality independent of body weight. Education is needed for all healthcare professionals in Ireland to address the gap in skills, increase knowledge of evidence-based practice, and eliminate bias and stigma in healthcare settings. We call for people living with obesity in Ireland to have access to evidence-informed care, including medical, medical nutrition therapy, physical activity and physical rehabilitation interventions, psychological interventions, pharmacotherapy, and bariatric surgery. This can be best achieved by resourcing and fully implementing the Model of Care for the Management of Adult Overweight and Obesity. To address health inequalities, we also call for the inclusion of obesity in the Structured Chronic Disease Management Programme and for pharmacotherapy reimbursement, to ensure equal access to treatment based on health-need rather than ability to pay.
Identifiants
pubmed: 36279848
pii: 000527131
doi: 10.1159/000527131
pmc: PMC9801383
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
736-752Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© 2022 The Author(s). Published by S. Karger AG, Basel.
Références
Qual Health Res. 2014 Apr 11;24(6):790-800
pubmed: 24728109
Med Educ. 2021 May;55(5):574-581
pubmed: 33155301
Healthcare (Basel). 2019 Feb 01;7(1):
pubmed: 30717197
Curr Obes Rep. 2017 Jun;6(2):195-203
pubmed: 28434109
Nat Rev Genet. 2022 Feb;23(2):120-133
pubmed: 34556834
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
J Acad Nutr Diet. 2017 Oct;117(10):1578-1611
pubmed: 28958344
J Am Coll Cardiol. 2018 Feb 13;71(6):670-687
pubmed: 29420964
Arch Gen Psychiatry. 2010 Mar;67(3):220-9
pubmed: 20194822
Lancet. 2010 Aug 21;376(9741):595-605
pubmed: 20673995
Diabetes Care. 2007 Jan;30(1):27-32
pubmed: 17192328
CMAJ. 2020 Aug 4;192(31):E875-E891
pubmed: 32753461
Trends Pharmacol Sci. 2015 Jul;36(7):461-70
pubmed: 26022934
Eur J Epidemiol. 2015 Sep;30(9):1009-19
pubmed: 26374741
Obes Facts. 2019;12(2):131-136
pubmed: 30844811
Appl Physiol Nutr Metab. 2011 Aug;36(4):570-6
pubmed: 21838602
Int J Obes (Lond). 2013 Nov;37(11):1443-51
pubmed: 23812094
Clin Obes. 2018 Dec;8(6):411-423
pubmed: 30241114
Obesity (Silver Spring). 2020 Mar;28(3):484-492
pubmed: 32090513
Adv Ther. 2021 Jul;38(7):4151
pubmed: 34081317
Obesity (Silver Spring). 2021 Apr;29 Suppl 1:S9-S24
pubmed: 33759395
Diabetes Educ. 2012 Jan-Feb;38(1):151-4
pubmed: 22328044
N Engl J Med. 2015 Jul 2;373(1):11-22
pubmed: 26132939
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Prim Health Care Res Dev. 2016 Jan;17(1):33-41
pubmed: 25777550
N Engl J Med. 2011 Oct 27;365(17):1597-604
pubmed: 22029981
JAMA. 2003 Jan 8;289(2):187-93
pubmed: 12517229
Lancet. 2015 Jun 20;385(9986):2521-33
pubmed: 25703112
BMC Public Health. 2009 Mar 25;9:88
pubmed: 19320986
Obes Rev. 2007 Sep;8(5):441-9
pubmed: 17716301
Obes Facts. 2020;13(3):297-306
pubmed: 32396899
PLoS One. 2021 Jul 9;16(7):e0253696
pubmed: 34242241
Physiol Behav. 2019 Feb 1;199:33-34
pubmed: 30414400
Can Fam Physician. 2013 Jan;59(1):27-31
pubmed: 23341653
Prim Health Care Res Dev. 2019 Jul 22;20:e116
pubmed: 32800008
PLoS One. 2021 Nov 29;16(11):e0260075
pubmed: 34843517
Obesity (Silver Spring). 2011 Feb;19(2):402-8
pubmed: 20948514
Surg Obes Relat Dis. 2008 Jan-Feb;4(1):6-10
pubmed: 18201668
Int J Mol Sci. 2019 May 13;20(9):
pubmed: 31085992
Obesity (Silver Spring). 2017 Apr;25(4):660-661
pubmed: 28349662
Healthcare (Basel). 2018 Jun 28;6(3):
pubmed: 29958395
Obes Rev. 2010 Nov;11(11):808-9
pubmed: 21182728
J Phys Act Health. 2017 May;14(5):389-407
pubmed: 28169568
Annu Rev Physiol. 2017 Feb 10;79:401-423
pubmed: 27912679
Diabetes Res Clin Pract. 2010 Sep;89(3):309-19
pubmed: 20493574
Pain. 2017 Jul;158(7):1342-1353
pubmed: 28383311
Physiol Rev. 2013 Jan;93(1):359-404
pubmed: 23303913
J Clin Invest. 2014 Oct;124(10):4473-88
pubmed: 25202980
Obesity (Silver Spring). 2006 Oct;14(10):1777-88
pubmed: 17062808
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
Diabetes Obes Metab. 2015 Sep;17(9):878-86
pubmed: 26094857
Obes Facts. 2020;13(5):514-527
pubmed: 33075798
Int J Obes (Lond). 2009 Mar;33(3):289-95
pubmed: 19188927
Am J Clin Nutr. 2008 Oct;88(4):906-12
pubmed: 18842775
Eur J Neurosci. 2012 Aug;36(3):2336-46
pubmed: 22712725
Ann Gastroenterol. 2021;34(3):404-414
pubmed: 33948067
Cell Metab. 2019 May 7;29(5):1078-1091.e5
pubmed: 30827863
Obesity (Silver Spring). 2022 Mar;30(3):577-586
pubmed: 35195367
CMAJ Open. 2021 Dec 7;9(4):E1141-E1148
pubmed: 34876416
Can J Diabetes. 2015 Aug;39(4):330-4
pubmed: 25837809
Obesity (Silver Spring). 2019 Jan;27(1):7-9
pubmed: 30569641
Obesity (Silver Spring). 2014 Jan;22(1):5-13
pubmed: 24307184
Soc Sci Med. 2010 Apr;70(7):1042-9
pubmed: 20106576
West J Med. 1999 Jun;170(6):348-51
pubmed: 18751155
Obes Rev. 2017 Jul;18(7):715-723
pubmed: 28489290
Endocrinol Metab Clin North Am. 2016 Sep;45(3):511-20
pubmed: 27519127
Ann N Y Acad Sci. 2018 Jan;1411(1):96-105
pubmed: 29044551
CMAJ. 2011 Oct 4;183(14):E1059-66
pubmed: 21844111
Clin Endocrinol (Oxf). 2021 Oct;95(4):531-541
pubmed: 33460482
Eur J Nutr. 2014 Dec;53(8):1591-601
pubmed: 25209031
Endocr Rev. 2006 Dec;27(7):750-61
pubmed: 17122359
Lancet. 2011 Aug 27;378(9793):804-14
pubmed: 21872749
J Obes. 2015;2015:619734
pubmed: 26060580
Med Clin North Am. 2018 Jan;102(1):183-197
pubmed: 29156185
Body Image. 2014 Jun;11(3):251-9
pubmed: 24958660
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Lancet. 2009 Mar 28;373(9669):1083-96
pubmed: 19299006
Lancet Diabetes Endocrinol. 2021 Jul;9(7):418
pubmed: 34087168
BMJ. 2007 Dec 8;335(7631):1194-9
pubmed: 18006966
Surg Obes Relat Dis. 2017 Jun;13(6):1052-1056
pubmed: 28256395
Transl Behav Med. 2021 Mar 16;11(2):642-652
pubmed: 32145022
Int J Obes (Lond). 2022 Mar;46(3):661-668
pubmed: 34974543
Psychol Sci. 2015 Nov;26(11):1803-11
pubmed: 26420442
Front Physiol. 2018 Jul 12;9:900
pubmed: 30050464
Endocr Pract. 2017 Mar;23(3):372-378
pubmed: 27967229
Lancet Diabetes Endocrinol. 2015 Feb;3(2):114-22
pubmed: 25483220
J Acad Nutr Diet. 2016 Jan;116(1):129-147
pubmed: 26718656
BMC Res Notes. 2015 Dec 22;8:810
pubmed: 26695407
Metabolism. 2020 Dec;113:154388
pubmed: 33035570